The bioscience department focuses on the molecular biology, epidemiology and immunology of infectious diseases with particular emphasis on the development of vaccines and understanding the transmission of pathogens. We work on malaria, viral pathogens, HIV and bacterial disease, and provide strategic direction to the Laboratory Research Platform

Our work on malaria covers the three life-cycle stages; gametocytes (where we are developing a human challenge model to test transmission blocking immunity and profiling the transmitting population in the community and developing markers of infectiousness); blood stage (where we are identifying the merozoite and red cell surface targets of human immunity and examining the role of parasite exposure on host immunity using a systems immunology approach); and pre-erythrocytic stages where we are examining vaccine-induced immunity.

Field surveillance for acute HIV infection and monitoring of a cohort and collaboration with IAVI has facilitated interests in functional assays (specifically the viral inhibition assay) and on the impact of transmitted drug resistance in Kenya.

We are undertaking work on the genomics of malaria, viral pathogens and bacterial pathogens in order to determine what the source of infection is (i.e. “who infects whom”) in collaboration with the Epidemiology and Demography Department.

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

91 to 100 of 446 Results
Jun 3, 2024
Nyagwange, James; Kutima, Bernadette; Mwai, Kennedy, 2024, "Replication Data for: Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro", https://doi.org/10.7910/DVN/LBSUYU, Harvard Dataverse, V2
This is a replication dataset for the publication titled: "Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro." The dataset used in this study included serum samples collected in 2018 in coastal Kenya from adults for malaria cross-sectional surveys, seru...
Jun 1, 2024 - Harvard Dataverse
Kiyuka, Patience, 2024, "Replication Data for: Understanding the barriers and facilitators of human papillomavirus vaccine uptake in Kwale and Mombasa counties in Kenya; A study protocol", https://doi.org/10.7910/DVN/JCUN7B, Harvard Dataverse, V1
Human papillomavirus (HPV) vaccine has been available since 2006 for adolescent girls and women in an increasing number of countries globally. Evidence suggests that the vaccine is safe, highly effective and essential for protecting against the virus that is responsible for causing cervical cancer, a leading killer disease in women. Our study seeks...
Add Data

Sign up or log in to create a dataverse or add a dataset.

Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.